Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity

Mariano Ubeda1, J Michael Rukstalis, Joel F Habener

  • 1Laboratory of Molecular Endocrinology, Harvard Medical School, Boston, MA 02115, USA.

Insights

Cyclin-dependent kinase 5 (CDK5) inhibition preserves pancreatic beta cell function in type 2 diabetes by maintaining PDX-1 nuclear localization, suggesting CDK5 inhibitors may treat this condition.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Neuroscience

Background:

  • Type 2 diabetes (T2D) and Alzheimer's disease share potential common mechanisms.
  • Overactive cyclin-dependent kinase 5 (CDK5) and p35 are implicated in neuronal dysfunction and may affect pancreatic beta cells.

Purpose of the Study:

  • To investigate the role of CDK5 and p35 in glucotoxicity-induced beta cell impairment in T2D.
  • To determine if CDK5 inhibition could protect beta cell function.

Main Methods:

  • Utilized the INS-1 pancreatic cell line as an in vitro model of glucotoxicity.
  • Employed roscovitine as a CDK5 inhibitor.
  • Assessed insulin gene expression, insulin promoter activity, and PDX-1 transcription factor levels via reporter assays, gel shifts, and Western immunoblots.

Main Results:

  • High glucose reduced insulin mRNA and promoter activity, which was prevented by CDK5 inhibition.
  • CDK5 inhibition preserved PDX-1 levels and its binding to the insulin promoter under glucotoxic conditions.
  • CDK5 inhibition maintained PDX-1 in the nucleus, preventing its translocation to the cytoplasm.

Conclusions:

  • CDK5 plays a critical role in the loss of pancreatic beta cell function caused by glucotoxicity in T2D.
  • CDK5 inhibitors demonstrate therapeutic potential for treating type 2 diabetes.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...